• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

99.96 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 887
Open 99.96
Bid (Size) 99.90 (200)
Ask (Size) 101.00 (100)
Prev. Close 99.96
Today's Range 99.96 - 99.96
52wk Range 49.67 - 111.86
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders
September 30, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
September 30, 2026
Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus' PSMA PET imaging agent 
From Lantheus Holdings, Inc.
Via GlobeNewswire

Performance

52-Week Range 10.6% below 52-week high
99.96
49.6752W Low 111.8652W High
1 Week 0.1% below 1-week high
99.311W Low 100.071W High

Lantheus Holdings, Inc. - Common Stock (LNTH) traded between $49.67 and $111.86 over the past 52 weeks and last traded at $99.96, 10.6% below its 52-week high. Over the past week it ranged between $99.31 and $100.07.

Past 12 Months
+0.2%
-1.0%
-2.8%
+31.7%
+48.6%
+89.7%
1W +$0.22
1M -$1.01
3M -$2.86
6M +$24.07
YTD +$32.69
1Y +$47.26

LNTH was +89.7% over the past year, +31.7% over six months, +48.6% year to date, +0.2% in the last week.

12 Months vs Market
LNTH
+89.7%
DIA
+9.5%
SPY
+14.6%
QQQ
+23.3%
IWM
+14.1%

Over the past 12 months LNTH returned +89.7% versus DIA (Dow) +9.5%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +23.3% and IWM (Russell 2000) +14.1%.

Volume & Liquidity 0.00× 3-mo avg
Today 887 3-mo avg 1.3M
1W
1.1M
1M
1.0M
3M
1.3M
6M
1.2M
YTD
1.1M
1Y
1.1M

LNTH most recently traded 887 shares against a 3-month average daily volume of 1.3M.

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SoundThinking, Inc. (Nasdaq – SSTI), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies Corporation (Nasdaq –
September 29, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
September 28, 2026
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, LNTH are Obtaining Fair Deals for their Shareholders
September 24, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
September 24, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
3 Reasons LNTH is Risky and 1 Stock to Buy Instead
September 23, 2026
Via StockStory
Topics Stocks
News headline image
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
September 22, 2026
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
2 Small-Cap Stocks to Consider Right Now and 1 That Underwhelm
September 11, 2026
Via StockStory
News headline image
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
September 10, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
August 29, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH)
August 19, 2026
Via StockStory
Topics Economy
News headline image
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
August 14, 2026
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether LNTH, BOW, SAFT are Obtaining Fair Deals for their Shareholders
August 11, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowman Consulting Group Ltd. (Nasdaq – BWMN), Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc.
August 11, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
August 07, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026
August 06, 2026
Via StockStory
News headline image
Lantheus Reports Second Quarter 2026 Financial Results
August 06, 2026
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Earnings To Watch: Lantheus (LNTH) Reports Q2 Results Tomorrow
August 04, 2026
Via StockStory
News headline image
Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders
August 04, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc. (Nasdaq – SAFT), Neuphoria Therapeutics Inc. (Nasdaq
August 04, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether LNTH, ATKR, INDV are Obtaining Fair Deals for their Shareholders
August 03, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
August 03, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Curium Announces Definitive Agreement to Merge with Lantheus
August 03, 2026
From Curium
Via GlobeNewswire
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Question
July 30, 2026
Via StockStory

Frequently Asked Questions

Is Lantheus Holdings, Inc. - Common Stock publicly traded?
Yes, Lantheus Holdings, Inc. - Common Stock is publicly traded.
What exchange does Lantheus Holdings, Inc. - Common Stock trade on?
Lantheus Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lantheus Holdings, Inc. - Common Stock?
The ticker symbol for Lantheus Holdings, Inc. - Common Stock is LNTH on the Nasdaq Stock Market
What is the current price of Lantheus Holdings, Inc. - Common Stock?
The current price of Lantheus Holdings, Inc. - Common Stock is 99.96
When was Lantheus Holdings, Inc. - Common Stock last traded?
The last trade of Lantheus Holdings, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Lantheus Holdings, Inc. - Common Stock?
The market capitalization of Lantheus Holdings, Inc. - Common Stock is 6.76B
How many shares of Lantheus Holdings, Inc. - Common Stock are outstanding?
Lantheus Holdings, Inc. - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap